• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌中HER-2/neu免疫组化表达的自动化定量评估

Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer.

作者信息

Masmoudi Hela, Hewitt Stephen M, Petrick Nicholas, Myers Kyle J, Gavrielides Marios A

机构信息

Department of Electrical and Computer Engineering, The George Washington University, Washington, DC 20052, USA.

出版信息

IEEE Trans Med Imaging. 2009 Jun;28(6):916-25. doi: 10.1109/TMI.2009.2012901. Epub 2009 Jan 19.

DOI:10.1109/TMI.2009.2012901
PMID:19164073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7238291/
Abstract

The expression of the HER-2/neu (HER2) gene, a member of the epidermal growth factor receptor family, has been shown to be a valuable prognostic indicator for breast cancer. However, interobserver variability has been reported in the evaluation of HER2 with immunohistochemistry. It has been suggested that automated computer-based evaluation can provide a consistent and objective evaluation of HER2 expression. In this manuscript, we present an automated method for the quantitative assessment of HER2 using digital microscopy. The method processes microscopy images from tissue slides with a multistage algorithm, including steps of color pixel classification, nuclei segmentation, and cell membrane modeling, and extracts quantitative, continuous measures of cell membrane staining intensity and completeness. A minimum cluster distance classifier merges the features to classify the slides into HER2 categories. An evaluation based on agreement analysis with pathologist-derived HER2 scores, showed good agreement with the provided truth. Agreement varied within the different classes with highest agreement (up to 90%) for positive (3+) slides, and lowest agreement (72%-78%) for equivocal (2+) slides which contained ambiguous scoring. The developed automated method has the potential to be used as a computer aid for the immunohistochemical evaluation of HER2 expression with the objective of increasing observer reproducibility.

摘要

HER-2/neu(HER2)基因是表皮生长因子受体家族的成员之一,其表达已被证明是乳腺癌一个有价值的预后指标。然而,据报道,在通过免疫组织化学评估HER2时存在观察者间的变异性。有人提出,基于计算机的自动化评估可以对HER2表达进行一致且客观的评估。在本论文中,我们提出了一种使用数字显微镜对HER2进行定量评估的自动化方法。该方法采用多阶段算法处理组织切片的显微镜图像,包括彩色像素分类、细胞核分割和细胞膜建模步骤,并提取细胞膜染色强度和完整性的定量、连续测量值。一个最小聚类距离分类器合并这些特征,将切片分类为HER2类别。基于与病理学家得出的HER2评分进行一致性分析的评估显示,与提供的真值具有良好的一致性。不同类别之间的一致性有所不同,阳性(3+)切片的一致性最高(高达90%),而包含模糊评分的 equivocal(2+)切片的一致性最低(72%-78%)。所开发的自动化方法有可能用作计算机辅助工具,用于HER2表达的免疫组织化学评估,目的是提高观察者的可重复性。

相似文献

1
Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer.乳腺癌中HER-2/neu免疫组化表达的自动化定量评估
IEEE Trans Med Imaging. 2009 Jun;28(6):916-25. doi: 10.1109/TMI.2009.2012901. Epub 2009 Jan 19.
2
Computer-assisted assessment of the human epidermal growth factor receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls.使用膜分离算法和阳性对照的定量分析对成像组织学切片中的人表皮生长因子受体2免疫组织化学检测进行计算机辅助评估。
BMC Med Imaging. 2008 Jun 5;8:11. doi: 10.1186/1471-2342-8-11.
3
AutoIHC-Analyzer: computer-assisted microscopy for automated membrane extraction/scoring in HER2 molecular markers.AutoIHC-Analyzer:用于 HER2 分子标志物的自动膜提取/评分的计算机辅助显微镜。
J Microsc. 2021 Jan;281(1):87-96. doi: 10.1111/jmi.12955. Epub 2020 Aug 27.
4
HER2 challenge contest: a detailed assessment of automated HER2 scoring algorithms in whole slide images of breast cancer tissues.HER2 挑战赛:乳腺癌组织全切片图像中自动化 HER2 评分算法的详细评估。
Histopathology. 2018 Jan;72(2):227-238. doi: 10.1111/his.13333. Epub 2017 Oct 27.
5
Can AI-assisted microscope facilitate breast HER2 interpretation? A multi-institutional ring study.人工智能辅助显微镜是否有助于乳腺癌 HER2 判读?一项多机构环研究。
Virchows Arch. 2021 Sep;479(3):443-449. doi: 10.1007/s00428-021-03154-x. Epub 2021 Jul 19.
6
Observer variability in the interpretation of HER2/neu immunohistochemical expression with unaided and computer-aided digital microscopy.无辅助和计算机辅助数字显微镜下 HER2/neu 免疫组织化学表达解读的观察者间变异性。
Arch Pathol Lab Med. 2011 Feb;135(2):233-42. doi: 10.5858/135.2.233.
7
Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays.通过 HER2 免疫组化的数字图像分析估计的膜连接与视觉评分和荧光原位杂交结果一致:乳腺癌组织微阵列的算法评估。
Diagn Pathol. 2011 Sep 23;6:87. doi: 10.1186/1746-1596-6-87.
8
Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy.使用数字显微镜提高HER-2/neu免疫组织化学评分的准确性和可靠性。
Am J Clin Pathol. 2004 May;121(5):620-30. doi: 10.1309/Y73U-8X72-B68T-MGH5.
9
Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis.HER2低表达乳腺癌的免疫组织化学评估:观察者间的可重复性及与数字图像分析的相关性
Breast Cancer Res Treat. 2024 Jun;205(2):403-411. doi: 10.1007/s10549-024-07256-3. Epub 2024 Mar 5.
10
Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTestTM in breast carcinoma by image analysis.通过图像分析,采用HercepTestTM对乳腺癌中HER2/neu表达进行定量免疫组化评估。
Pathol Int. 2001 Jan;51(1):33-6. doi: 10.1046/j.1440-1827.2001.01162.x.

引用本文的文献

1
AI microscope facilitates accurate interpretation of HER2 immunohistochemical scores 0 and 1+ in invasive breast cancer.人工智能显微镜有助于准确解读浸润性乳腺癌中HER2免疫组化评分为0和1+的情况。
Sci Rep. 2025 Aug 11;15(1):29289. doi: 10.1038/s41598-025-13820-8.
2
Computational approach for counting of SISH amplification signals for HER2 status assessment.用于HER2状态评估的SISH扩增信号计数的计算方法。
PeerJ Comput Sci. 2024 Oct 23;10:e2373. doi: 10.7717/peerj-cs.2373. eCollection 2024.
3
Review of In Situ Hybridization (ISH) Stain Images Using Computational Techniques.

本文引用的文献

1
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.美国临床肿瘤学会/美国病理学家学会关于乳腺癌中人表皮生长因子受体2检测的指南建议
Arch Pathol Lab Med. 2007;131(1):18-43. doi: 10.5858/2007-131-18-ASOCCO.
2
Cooperation of color pixel classification schemes and color watershed: a study for microscopic images.颜色像素分类方案与颜色分水岭的协作:用于显微镜图像的研究。
IEEE Trans Image Process. 2002;11(7):783-9. doi: 10.1109/TIP.2002.800889.
3
HER2 and response to paclitaxel in node-positive breast cancer.
使用计算技术对原位杂交(ISH)染色图像进行综述。
Diagnostics (Basel). 2024 Sep 21;14(18):2089. doi: 10.3390/diagnostics14182089.
4
High contrast breast cancer biomarker semi-quantification and immunohistochemistry imaging using upconverting nanoparticles.使用上转换纳米颗粒进行高对比度乳腺癌生物标志物的半定量和免疫组织化学成像。
Biomed Opt Express. 2024 Jan 19;15(2):900-909. doi: 10.1364/BOE.504939. eCollection 2024 Feb 1.
5
Deep Learning-Based H-Score Quantification of Immunohistochemistry-Stained Images.基于深度学习的免疫组化染色图像 H 评分定量分析。
Mod Pathol. 2024 Feb;37(2):100398. doi: 10.1016/j.modpat.2023.100398. Epub 2023 Dec 1.
6
Immunohistochemical HER2 Recognition and Analysis of Breast Cancer Based on Deep Learning.基于深度学习的乳腺癌免疫组化HER2识别与分析
Diagnostics (Basel). 2023 Jan 10;13(2):263. doi: 10.3390/diagnostics13020263.
7
Determining HER2 Status by Artificial Intelligence: An Investigation of Primary, Metastatic, and HER2 Low Breast Tumors.通过人工智能确定HER2状态:对原发性、转移性和HER2低表达乳腺肿瘤的研究
Diagnostics (Basel). 2023 Jan 3;13(1):168. doi: 10.3390/diagnostics13010168.
8
Using Whole Slide Gray Value Map to Predict HER2 Expression and FISH Status in Breast Cancer.利用全切片灰度值图预测乳腺癌中的HER2表达和荧光原位杂交状态
Cancers (Basel). 2022 Dec 17;14(24):6233. doi: 10.3390/cancers14246233.
9
A Deep Learning Quantification Algorithm for HER2 Scoring of Gastric Cancer.一种用于胃癌HER2评分的深度学习量化算法。
Front Neurosci. 2022 May 30;16:877229. doi: 10.3389/fnins.2022.877229. eCollection 2022.
10
Changing Trends in Estrogen Receptors/Progesterone Receptors/Human Epidermal Growth Factor Receptor 2 Prevalence Rates Among Jordanian Patients With Breast Cancer Over the Years.多年来约旦乳腺癌患者中雌激素受体/孕激素受体/人表皮生长因子受体 2 阳性率的变化趋势。
JCO Glob Oncol. 2022 Mar;8:e2100359. doi: 10.1200/GO.21.00359.
人表皮生长因子受体2(HER2)与淋巴结阳性乳腺癌对紫杉醇的反应
N Engl J Med. 2007 Oct 11;357(15):1496-506. doi: 10.1056/NEJMoa071167.
4
Assessment of medical imaging systems and computer aids: a tutorial review.医学成像系统与计算机辅助设备评估:教程综述
Acad Radiol. 2007 Jun;14(6):723-48. doi: 10.1016/j.acra.2007.03.001.
5
Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis.人表皮生长因子受体2阳性乳腺癌的检测:一项系统评价与成本效益分析
CMAJ. 2007 May 8;176(10):1429-34. doi: 10.1503/cmaj.061011.
6
Immunohistochemistry and quantitative analysis of protein expression.免疫组织化学及蛋白质表达的定量分析。
Arch Pathol Lab Med. 2006 Jul;130(7):1026-30. doi: 10.5858/2006-130-1026-IAQAOP.
7
HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.乳腺癌中HER-2状态:采用先进细胞成像系统的荧光原位杂交法检测基因扩增与免疫组化表达的相关性
Appl Immunohistochem Mol Morphol. 2006 Jun;14(2):132-7. doi: 10.1097/01.pai.0000150516.75567.13.
8
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.辅助多西他赛或长春瑞滨联合或不联合曲妥珠单抗用于乳腺癌治疗。
N Engl J Med. 2006 Feb 23;354(8):809-20. doi: 10.1056/NEJMoa053028.
9
A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.一种用于预测他莫昔芬治疗的乳腺癌患者预后的多标志物模型。
Clin Cancer Res. 2006 Feb 15;12(4):1175-83. doi: 10.1158/1078-0432.CCR-05-1562.
10
TOR signaling in growth and metabolism.生长与代谢中的TOR信号传导
Cell. 2006 Feb 10;124(3):471-84. doi: 10.1016/j.cell.2006.01.016.